39 results
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Summary table of ... Selective factor Xa inhibitors ... anticoagulation #pharmacology ... #medications #doac ... #comparison #table
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
Antiplatelet Medications ... - Summary Table ... #Antiplatelet #Medications ... #Summary #Table ... #Pharmacology
HIV Antiretroviral Medications Cheat Sheet

NRTIs
Integrase Inhibitors
NNRTIs
PIs
Fusion Inhibitors
CCR5 Antagonist
Post Attachment Inhibitor
Combination Pills
NRTI-Sparing
Resistance Mutations Summary - https://hivdb.stanford.edu/ 

By
Antiretroviral Medications ... NRTIs Integrase Inhibitors ... Post Attachment Inhibitor ... Resistance Mutations Summary ... Classification #Pharmacology
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
Summary of characteristics ... Platelet Aggregation Inhibitors ... #AntiPlatelet #Inhibitors ... #Pharmacology # ... Table #Overview
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
inducers (↑) and inhibitors ... concentrations, and inhibitors ... by inducers or inhibitors ... #Interactions #Table ... #Pharmacology
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
anticoagulation in North America ... per treatment table ... direct thrombin inhibitor ... Rivaroxaban (anti-XA inhibitor ... Management #Treatment #pharmacology
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Summary of Diuretic ... others SGLT2 INHIBITORS ... #Diuretics #Medications ... #Pharmacology # ... summary #table #
Indications for and pharmacological properties of approved SGLT2 inhibitors

Canagliflozin - Dapagliflozin - Empagliflozin - Ertugliflozin

#SGLT2 #Inhibitors
Indications for ... approved SGLT2 inhibitors ... Ertugliflozin #SGLT2 #Inhibitors ... #pharmacology # ... table
Summary of Coagulation Deficiencies
Inherited:
 • Hemophilia A - Deficiency of Factor VIII
 • Hemophilia B -
Summary of Coagulation ... Anticoagulant Medications ... LMWH, warfarin, DOACs ... #Deficiencies #Summary ... #table #comparison
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... events TZDs DPP-4 inhibitors ... SGLT2 inhibitors ... #table #comparison